Aria Pharmaceuticals

About:

Aria Pharmaceuticals is a artificial intelligence-driven biopharmaceutical company.

Website: https://ariapharmaceuticals.com/

Twitter/X: ariapharma

Top Investors: Andreessen Horowitz, Future Planet Capital, Network.VC, SBVA, StartX (Stanford-StartX Fund)

Description:

Aria Pharmaceuticals is a preclinical-stage pharmaceutical company discovering and developing novel small molecule therapies for complex and hard-to-treat diseases. Too many patients today are in need of breakthrough treatments across many complicated diseases – they can't wait. That's why at Aria, we have redefined the drug discovery approach, saving years in the process and increasing success rates 30 times higher than traditional methods. At Aria, we've shown promise across a diverse range of therapeutic areas with the ability to address over 1,000 diseases.

Total Funding Amount:

$14.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Palo Alto, California, United States

Founded Date:

2014-01-01

Founders:

Andrew A. Radin, Andrew M. Radin

Number of Employees:

11-50

Last Funding Date:

2021-07-09

IPO Status:

Private

© 2024 MyAiNote.com